357,469 Shares in Marsh & McLennan Companies, Inc. $MRSH Bought by L1 Capital International Pty Ltd

Key Points

• L1 Capital International Pty Ltd initiated a new position in Marsh & McLennan Companies, buying 357,469 shares valued at about $66.3 million. The stake represents roughly 3.4% of its portfolio.
• Several other institutional investors also increased their holdings, and overall 87.99% of the stock is owned by institutions. Meanwhile, CEO John Q. Doyle sold 16,656 shares in a pre-arranged transaction.
• Analyst views are mixed, with a consensus rating of "Hold" and a target price of $200.19. The stock was trading up modestly, and the company recently beat quarterly EPS estimates with $3.29 per share on $7.30 billion in revenue.

L1 Capital International Pty Ltd bought a new position in Marsh & McLennan Companies, Inc. (NYSE:MRSH - Free Report) during the fourth quarter, according to its most recent disclosure with the SEC. The firm bought 357,469 shares of the financial services provider's stock, valued at approximately $66,318,000. Marsh & McLennan Companies accounts for about 3.4% of L1 Capital International Pty Ltd's investment portfolio, making the stock its 14th biggest holding. L1 Capital International Pty Ltd owned approximately 0.07% of Marsh & McLennan Companies at the end of the most recent quarter.

A number of other institutional investors also recently bought and sold shares of the stock. Numerai GP LLC raised its holdings in Marsh & McLennan Companies by 966.2% during the third quarter. Numerai GP LLC now owns 37,220 shares of the financial services provider's stock valued at $7,501,000 after acquiring an additional 33,729 shares during the period. Swiss Life Asset Management Ltd raised its holdings in Marsh & McLennan Companies by 9.5% during the fourth quarter. Swiss Life Asset Management Ltd now owns 134,542 shares of the financial services provider's stock valued at $24,960,000 after acquiring an additional 11,648 shares during the period. Barclays PLC raised its holdings in Marsh & McLennan Companies by 41.7% during the third quarter. Barclays PLC now owns 2,202,372 shares of the financial services provider's stock valued at $443,844,000 after acquiring an additional 647,987 shares during the period. Sarasin & Partners LLP raised its holdings in Marsh & McLennan Companies by 0.9% during the fourth quarter. Sarasin & Partners LLP now owns 934,732 shares of the financial services provider's stock valued at $173,411,000 after acquiring an additional 8,283 shares during the period. Finally, Brown Brothers Harriman & Co. grew its position in shares of Marsh & McLennan Companies by 26.4% during the third quarter. Brown Brothers Harriman & Co. now owns 136,179 shares of the financial services provider's stock valued at $27,444,000 after purchasing an additional 28,419 shares in the last quarter. 87.99% of the stock is owned by institutional investors.

Insider Buying and Selling

In related news, CEO John Q. Doyle sold 16,656 shares of Marsh & McLennan Companies stock in a transaction dated Tuesday, June 2nd. The stock was sold at an average price of $161.71, for a total value of $2,693,441.76. Following the completion of the transaction, the chief executive officer owned 116,811 shares in the company, valued at approximately $18,889,506.81. This trade represents a 12.48% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Corporate insiders own 0.38% of the company's stock.

Wall Street Analyst Weigh In

MRSH has been the subject of a number of research analyst reports. Bank of America cut their price objective on Marsh & McLennan Companies from $181.00 to $174.00 and set an "underperform" rating for the company in a research report on Tuesday, April 14th. Keefe, Bruyette & Woods raised their price objective on Marsh & McLennan Companies from $200.00 to $203.00 and gave the company a "market perform" rating in a research report on Friday, April 17th. JPMorgan Chase & Co. cut their price objective on Marsh & McLennan Companies from $226.00 to $206.00 and set an "overweight" rating for the company in a research report on Thursday, April 9th. Raymond James Financial upgraded Marsh & McLennan Companies from an "outperform" rating to a "strong-buy" rating and set a $225.00 price objective for the company in a research report on Tuesday, February 17th. Finally, Citigroup upgraded Marsh & McLennan Companies from a "neutral" rating to a "buy" rating and set a $200.00 price objective for the company in a research report on Wednesday, May 6th. One equities research analyst has rated the stock with a Strong Buy rating, six have given a Buy rating, ten have issued a Hold rating and one has assigned a Sell rating to the company's stock. According to MarketBeat.com, Marsh & McLennan Companies has a consensus rating of "Hold" and a consensus target price of $200.19.

Marsh & McLennan Companies Trading Up 0.3%

MRSH opened at $168.67 on Friday. The stock has a market capitalization of $81.49 billion, a P/E ratio of 21.08, a P/E/G ratio of 2.45 and a beta of 0.62. Marsh & McLennan Companies, Inc. has a 12 month low of $156.60 and a 12 month high of $220.32. The company has a quick ratio of 1.11, a current ratio of 1.11 and a debt-to-equity ratio of 1.28.

Marsh & McLennan Companies (NYSE:MRSH - Get Free Report) last released its quarterly earnings results on Thursday, April 16th. The financial services provider reported $3.29 EPS for the quarter, topping the consensus estimate of $3.21 by $0.08. The company had revenue of $7.30 billion during the quarter. Marsh & McLennan Companies had a return on equity of 31.87% and a net margin of 14.26%.The company's quarterly revenue was up 7.6% compared to the same quarter last year. On average, analysts expect that Marsh & McLennan Companies, Inc. will post 10.38 earnings per share for the current year.

Marsh & McLennan Companies Company Profile

Marsh & McLennan Companies NYSE: MMC is a global professional services firm headquartered in New York City that provides advice and solutions in the areas of risk, strategy and people. Founded in 1905, the company has grown into a diversified group of businesses focused on insurance brokerage and risk management, reinsurance, human capital and investment consulting, and management consulting. Its long history and scale position it as a prominent adviser to corporations, governments and other institutions seeking to manage risk and optimize human and financial capital.

The firm operates through several well-known subsidiaries and business units that specialize in distinct services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.